We ask healthcare professionals to support new guidance for users of diabetes management equipment, their families, care givers and representatives.
UK Drug Safety Update · October 24, 2024
Insulin pumps and continuous glucose monitoring equipment: guidance for users on reporting suspected adverse incidents and safety concerns to the MHRA's Yellow Card scheme
Original title: Insulin pumps and continuous glucose monitoring (CGM) equipment: guidance for users on reporting suspected adverse incidents and safety concerns to the MHRA’s Yellow Card scheme
MHRA issues guidance for users of insulin pumps and CGM equipment on reporting suspected adverse incidents and safety concerns via the Yellow Card scheme.
Published by UK Drug Safety Update. HealthSignal links to the original document; the summary above is extracted from the source text.